Jefferies Financial Group Inc. Sarepta Therapeutics, Inc. Put Options Transaction History

Jefferies Financial Group Inc.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 13, 2024	SELL	$67.31 - $124.76 $908,685 - $1.68 Million	-13,500 Reduced 78.49%	3,700 $356,000
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $2.07 Million - $3.07 Million	-19,500 Reduced 53.13%	17,200 $1.97 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $11.8 Million - $15.7 Million	-100,800 Reduced 73.31%	36,700 $5.06 Million
Q4 2022 Sep 21, 2023	BUY	$100.86 - $132.13 $12.1 Million - $15.9 Million	120,300 Added 699.42%	137,500 $17.8 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $13.9 Million - $18.2 Million	137,500 New	137,500 $17.8 Million

528

83.9M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.2B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.